Search research articles
Contact Us
Filters
Showing results (141-150 of 174) with videos related to
Page
of 18
Sort By:
The Journal of Pharmacology and Experimental Therapeutics
|
December 7, 2007
Thionamides inhibit the transcription factor nuclear factor-kappaB by suppression of Rac1 and inhibitor of kappaB kinase alpha
Matjaz Humar, Hannah Dohrmann, Philipp Stein, et al.
Anesthesiology
|
May 26, 2005
Volatile anesthetics induce caspase-dependent, mitochondria-mediated apoptosis in human T lymphocytes in vitro
Torsten Loop, David Dovi-Akue, Michael Frick, et al.
Hemasphere
|
November 15, 2019
LSD1 Inhibition Prolongs Survival in Mouse Models of MPN by Selectively Targeting the Disease Clone
Jonas S Jutzi, Maria Kleppe, Jennifer Dias, et al.
Nature Genetics
|
March 17, 2009
JAK2 haplotype is a major risk factor for the development of myeloproliferative neoplasms
Amy V Jones, Andrew Chase, Richard T Silver, et al.
Oncogene
|
November 12, 2013
Increased leukocyte survival and accelerated onset of lymphoma in the absence of MCL-1 S159-phosphorylation
S E Lindner, M Wissler, A Gründer, et al.
International Journal of Molecular Sciences
|
December 30, 2025
NFE2 Truncation Mutants Protect Wild-Type NFE2 from ITCH-Dependent Degradation
Mirjam Elisabeth Hoeness, Franziska Zell, Titiksha Basu, et al.
Leukemia
|
October 23, 2019
Enhanced expression of the sphingosine-1-phosphate-receptor-3 causes acute myelogenous leukemia in mice
Samuel Vorbach, Albert Gründer, Fengbiao Zhou, et al.
The Journal of Cell Biology
|
December 1, 1996
Treatment of melanoma cells with the synthetic retinoid CD437 induces apoptosis via activation of AP-1 in vitro, and causes growth inhibition in xenografts in vivo
D Schadendorf, M A Kern, M Artuc, et al.
Experimental Hematology
|
August 2, 2017
The oligodendrocyte lineage transcription factor 2 (OLIG2) is epigenetically regulated in acute myeloid leukemia
Arzu Yalcin, Marlon Kovarbasic, Julius Wehrle, et al.
Blood
|
February 7, 2012
Genetic defects in PRC2 components other than EZH2 are not common in myeloid malignancies
Leonie I Kroeze, Gorica Nikoloski, Pedro da Silva-Coelho, et al.
Page
of 18
Search research articles
Search
Showing results (141-150 of 174) with videos related to
Sort By:
Page
of 18
The Journal of Pharmacology and Experimental Therapeutics
|
December 7, 2007
Thionamides inhibit the transcription factor nuclear factor-kappaB by suppression of Rac1 and inhibitor of kappaB kinase alpha
Matjaz Humar, Hannah Dohrmann, Philipp Stein, et al.
Anesthesiology
|
May 26, 2005
Volatile anesthetics induce caspase-dependent, mitochondria-mediated apoptosis in human T lymphocytes in vitro
Torsten Loop, David Dovi-Akue, Michael Frick, et al.
Hemasphere
|
November 15, 2019
LSD1 Inhibition Prolongs Survival in Mouse Models of MPN by Selectively Targeting the Disease Clone
Jonas S Jutzi, Maria Kleppe, Jennifer Dias, et al.
Nature Genetics
|
March 17, 2009
JAK2 haplotype is a major risk factor for the development of myeloproliferative neoplasms
Amy V Jones, Andrew Chase, Richard T Silver, et al.
Oncogene
|
November 12, 2013
Increased leukocyte survival and accelerated onset of lymphoma in the absence of MCL-1 S159-phosphorylation
S E Lindner, M Wissler, A Gründer, et al.
International Journal of Molecular Sciences
|
December 30, 2025
NFE2 Truncation Mutants Protect Wild-Type NFE2 from ITCH-Dependent Degradation
Mirjam Elisabeth Hoeness, Franziska Zell, Titiksha Basu, et al.
Leukemia
|
October 23, 2019
Enhanced expression of the sphingosine-1-phosphate-receptor-3 causes acute myelogenous leukemia in mice
Samuel Vorbach, Albert Gründer, Fengbiao Zhou, et al.
The Journal of Cell Biology
|
December 1, 1996
Treatment of melanoma cells with the synthetic retinoid CD437 induces apoptosis via activation of AP-1 in vitro, and causes growth inhibition in xenografts in vivo
D Schadendorf, M A Kern, M Artuc, et al.
Experimental Hematology
|
August 2, 2017
The oligodendrocyte lineage transcription factor 2 (OLIG2) is epigenetically regulated in acute myeloid leukemia
Arzu Yalcin, Marlon Kovarbasic, Julius Wehrle, et al.
Blood
|
February 7, 2012
Genetic defects in PRC2 components other than EZH2 are not common in myeloid malignancies
Leonie I Kroeze, Gorica Nikoloski, Pedro da Silva-Coelho, et al.
Page
of 18